Table 1.
Characteristics of the study population
| Total population, n=719 | |
| Age, mean (SD), years | 81 (10) |
| Sex, n (%) male | 345 (48) |
| Housing before admission (%) | |
| Home without homecare | 403 (56) |
| Home with homecare | 169 (24) |
| Nursing home | 146 (20) |
| Length of stay, median days (IQR) | |
| In the hospital | 10 (6–16) |
| In the ward | 8 (5–14) |
| No of drugs, median (IQR) | |
| At admission | |
| Continuous use | 7 (5–11) |
| As needed | 1 (0–2) |
| At discharge | |
| Continuous use | 8 (5–11) |
| As needed | 2 (1–3) |
| During the hospital stay | |
| Initiated | 2 (1–4) |
| Stopped | 1 (0–3) |
| Renal function reduction, n (%)* | |
| No reduction | 84 (11.7) |
| Mild, GFR 60–89 mL/min | 157 (21.8) |
| Moderate, GFR 30–59 mL/min | 313 (43.5) |
| Severe, GFR 15–29 mL/min | 115 (16.0) |
| Kidney failure, GFR <15 mL/min | 14 (1.9) |
| No information | 36 (5.0) |
| Drug allergy or hypersensitivity documented in the EHR, n (%) | 133 (18.5) |
*Renal function was calculated using the Cockroft-Gault equation.
EHR, electronic health record; GFR, glomerular filtration rate.